GHK-Cu Copper peptide 50 mg

GHK-CU (50mg) — Research Compound

GHK-Cu is a naturally occurring copper complex of the tripeptide glycyl-L-histidyl-L-lysine, extensively researched for its role in cellular repair, tissue remodeling, and regenerative signaling pathways. In research settings, GHK-Cu is studied for its ability to influence extracellular matrix regulation, inflammation control, and oxidative stress responses, with particular interest in its capacity to recalibrate cellular gene expression toward a more youthful profile.

Findings from early-stage clinical trials have reported:

• Significant increases in collagen, elastin, and glycosaminoglycan production observed in dermal cell cultures.
• Improved rates of wound contraction and enhanced tissue regeneration reported in experimental models.
• Reductions in pro-inflammatory cytokine levels and increased antioxidant enzyme activity noted in-vivo.
• Observed improvements in skin thickness, firmness, and wrinkle depth reported across study cohorts.

Researchers study GHK-Cu to investigate the biological mechanisms underlying tissue repair, extracellular matrix maintenance, and oxidative damage mitigation, with additional interest in its potential relevance to wound healing and the protection of lung and nerve tissues from oxidative damage.

Available Formats:
This compound is available as a vial of lyophilised powder, or can be ordered in a disposable pen, a reusable pen, or a cartridge for an existing reusable pen system.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use